4.2 Article

Chronic Fatigue Syndrome (CFS) and Cancer Related Fatigue (CRF): two fatigue syndromes with overlapping symptoms and possibly related aetiologies

期刊

NEUROMUSCULAR DISORDERS
卷 22, 期 -, 页码 S235-S241

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.nmd.2012.10.018

关键词

Chronic Fatigue Syndrome; Cancer Related Fatigue; Xenotropic Murine Related Virus

向作者/读者索取更多资源

In July 2010, at the Muscle Fatigue Meeting, I presented an overview of Chronic Fatigue Syndrome and Cancer Related Fatigue, emphasizing a critical interpretation of the potential association between Chronic Fatigue Syndrome and Cancer Related Fatigue and a newly discovered retrovirus: Xenotropic Murine Related Virus. Since this association was hotly debated at that time, I suggested at the Meeting that it was wrong and most likely due to the identification of the wrong virus culprit. Today, 20 months after the Meeting, the first part of our prediction has turned out to be correct, as Xenotropic Murine Related Virus was shown to be a laboratory-created artefact. Still, the potential association of fatigue-syndromes with an infection (most likely viral) is sustained by a plethora of evidence and this overview will initially summarize data suggesting prior viral infection(s). The principal hypothesized mechanisms for both peripheral and central Chronic Fatigue Syndrome/Cancer Related Fatigue will be then summarized, also indicating plausible associations and triggering factors. All evidence accrued so far suggests that further research work should be performed in this interesting area and in order to identify an infectious agent for Chronic Fatigue Syndrome/Cancer Related Fatigue. One candidate RNA virus, Micro-Foci inducing Virus, will be described in this overview. (C) 2012 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Oncology

Cancer modelling in the NGS era - Part I: Emerging technology and initial modelling

Ugo Rovigatti

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)

Letter Hematology

Immunosuppressive treatments in Crohn's disease induce myelodysplasia and leukaemia

Andrea Piccin, Sergio Cortelazzo, Ugo Rovigatti, Billy Bourke, Owen P. Smith

AMERICAN JOURNAL OF HEMATOLOGY (2010)

Editorial Material Urology & Nephrology

Of Mice and Men - Viruses and Prostate Cancer: What Is the Next Step?

Ugo Rovigatti, Cesare Selli, Riccardo Bartoletti

EUROPEAN UROLOGY (2010)

Letter Oncology

Transition of idiopathic CD4 + lymphocytopenia into mycosis fungoides?

Andrea Piccin, Klaus Eisendle, Ugo Rovigatti, Michael Steurer, Martina Tauber, Daisy Corvetta, Guido Mazzoleni, Mirija Svaldi, Guenther Gastl, Sergio Cortelazzo

LEUKEMIA & LYMPHOMA (2014)

Letter Cell Biology

Essential thrombocytemia progressing to Ph plus chronic myeloid leukemia with megakaryoblastic blasts, following anagrelide withdrawal

Andrea Piccin, Daisy Corvetta, Ugo Rovigatti, Guido Mazzoleni, Irene Pusceddu, Mirija Svaldi, Michael Steurer, Guether Gastl, Sergio Cortelazzo

PLATELETS (2014)

Review Oncology

The glycosphingolipid GD2 as an effective but enigmatic target of passive immunotherapy in children with aggressive neuroblastoma (HR-NBL)

Ugo Rovigatti

Summary: Neuroblastoma is a common and lethal pediatric cancer with extreme heterogeneity, utilizing GD2-IMT to target GD2 on NBL cells can increase remission length in high-risk cases. The alternative model of Micro-Foci inducing virus (MFV) suggests a potential association between GD2 and the efficacy of anti-GD2 therapies.

CANCER LETTERS (2021)

Meeting Abstract Oncology

Efforts to define biochemical and pharmacologic pathways potentially beneficial to both cancer and COVID-19 patients.

Ugo Rovigatti, Amedeo Vannacci, Simone Del Corto, Ignacio Martin-Loeches, Andrea Piccin, Nizar Naji, Carmel Mothersill

CLINICAL CANCER RESEARCH (2020)

Meeting Abstract Infectious Diseases

HIV/HPV CO-INFECTION: MONITORING AND TREATMENT IN SUB-SAHARAN AFRICA: A PUBLIC HEALTH MODEL INTERVENTION

G. Guidotti, C. Moscatelli, L. Palombi, M. C. Marazzi, C. Carrilho, E. S. F. Walle, I. Zimba, M. Magnano San Lio, F. Erba, M. Cunha, U. Rovigatti, I. Marchetti, M. P. Cioni, G. Bevilacqua

INFECTION (2011)

Meeting Abstract Hematology

THIOPURINE S-METHYL TRANSFERASE POLYMORPHIC STATUS, 6-MERCAPTOPURINE, AND TNF-ALPHA ANTAGONISM IN THE DEVELOPMENT OF MYELODYSPLASTIC SYNDROME/MONOSOMY 7 IN A CHILD WITH CROHN'S DISEASE

A. Piccin, U. Rovigatti, C. Mc Mahon, J. Kelly, B. Bourke, A. O'Marcaigh, O. P. Smith

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)

Article Oncology

Erythroleukaemia, diabetes insipidus and hypophyseal damage: Two case reports

A. Piccin, R. Raimondi, S. Laspina, M. Marchi, F. Rodeghiero, U. Rovigatti

LEUKEMIA RESEARCH (2007)

Meeting Abstract Biochemistry & Molecular Biology

MICRO-FOCI INDUCING VIRUS (MFV), A MARKER OF PAEDIATRIC CANCERS, BEHAVES AS A STEM CELL VIRUS

Ugo Rovigatti

IUBMB LIFE (2009)

暂无数据